title: Iron and hepatitis C: what can we learn from thalassemia major?
authors.forename: Amira
authors.initials: A
authors.lastname: Mahmoud
authors.forename: Khaled M
authors.initials: KM
authors.lastname: Musallam
authors.forename: Ali T
authors.initials: AT
authors.lastname: Taher
mesh_terms: D000328:Adult; D001565:Benzoates / Q000627:therapeutic use; D015913:Chelation Therapy; D000077588:Deferasirox; D003676:Deferoxamine / Q000627:therapeutic use; D005260:Female; D005293:Ferritins / Q000097:blood; D016174:Hepacivirus / Q000235:genetics / Q000302:isolation & purification; D019698:Hepatitis C, Chronic / Q000097:blood / Q000628:therapy*; D006801:Humans; D007501:Iron / Q000097:blood; D000090463:Iron Deficiencies; D008297:Male; D018962:Phlebotomy; D017262:Siderophores / Q000627:therapeutic use; D014230:Triazoles / Q000627:therapeutic use; D017086:beta-Thalassemia / Q000097:blood / Q000628:therapy*
chemical_list: D001565:Benzoates; D017262:Siderophores; D014230:Triazoles; D005293:Ferritins; D007501:Iron; D003676:Deferoxamine; D000077588:Deferasirox